tiprankstipranks

Lava Therapeutics reports Q1 EPS (13c) vs (2c) last year

“LAVA’s top priority remains delivering shareholder value through an evaluation of strategic alternatives,” said Steve Hurly, Chief Executive Officer of LAVA. “To support this process, we have taken actions to streamline our operations by implementing a significant reduction in workforce as part of a restructuring plan, which includes the closure of our Netherlands operations. In addition, we secured a $5.2 million repayment waiver from the Netherlands Enterprise Agency. We look forward to providing further updates on LAVA-1266, partnered programs and the evaluation of strategic alternatives.”

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue